Company intelligence / Profile preview
CytoImmune Therapeutics
Duarte, California, United Statescytoimmune.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Phase 1
01
Overview
CytoImmune Therapeutics has developed proprietary platforms to engineer off-the-shelf allogeneic NK cell therapies that directly attack tumor cells while stimulating both innate and adaptive immunity. Their lead programs are in clinical development for solid tumors such as non-small cell lung cancer. The company leverages advanced manufacturing capabilities in Puerto Rico to rapidly deliver therapies within days rather than weeks. Early results focus on safety/feasibility; detailed efficacy data have not yet been published.[2][3][7]
- Therapeutic areas
- OncologyImmunology
- Modalities
- Engineered allogeneic natural killer (NK) cells (including CAR-NK™)Bispecific Killer Engager (BiKE) molecules
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Licensed core technology from City of Hope National Medical Center laboratories of Drs. Michael Caligiuri & Jianhua Yu[8]. No major pharma partnerships publicly disclosed.
Beyond the preview
Go deeper on CytoImmune Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CytoImmune Therapeutics.